Lot No: 1
II.2.1) Title
A mass spectrometry imaging system incorporating a matrix assisted laser desorption ionisation source, an electrospray source3 and nhplc/uplc system(s)
II.2.2) Additional CPV code(s)
38433100
II.2.3) Place of performance
NUTS code:
UKE32
II.2.4) Description of the procurement
The project is receiving up to £2.7M of funding from the England European Regional Development Fund as part of the European Structural and Investment Funds Growth Programme 2014-2020. The Ministry of Housing, Communities and Local Government (and in London the intermediate body Greater London Authority) is the Managing Authority for European Regional Development Fund. Established by the European Union, the European Regional Development Fund helps local areas stimulate their economic development by investing in projects which will support innovation, businesses, create jobs and local community regenerations. For more information visit https://www.gov.uk/european-growth-funding
The Northern Powerhouse is a key aspect of this Government's approach to addressing the productivity gap in the North and ensuring a stronger, more sustainable economy for all parts of the UK. Alongside over €1.5 billion of European Regional Development Fund support for businesses and communities across the North, the government has awarded £3.4 billion in three rounds of Growth Deals across the Northern Powerhouse.
The likely use of the MALDI Mass Spectrometer will be in the analysis of molecules in a range of biological and chemical samples. Industry sectors that this will impact will be: Chemical manufacturers, pharmaceutical companies, forensic testing, agricultural product manufacturers and food & beverage companies. The benefits / likely outcomes are efficacy and safety testing of existing or new products (validated research materials for marketing purposes, compliance with product regulations). Also, identification of mode of action of products (novel used of existing products).
The likely use of the Integrated AFM-Raman Imaging System will be in biotech, pharmaceuticals, high precision engineering, NHS, and Private healthcare centres and SMEs developing new products.
The likely use of the MicroCT (Computerised Tomography) Scanner will be in private healthcare centres and SMEs developing bone implants for downstream analysis. Companies undertaking R&D in biomaterials and bone material science applications in geology and environmental analysis. The benefits / likely outcomes are development of new materials for bone formation and regeneration. Non-destructive analysis of implants and testing of novel drugs.
The medium to longer term objectives, year 2 onwards, include work with business and academic partners to:
• Develop new materials, products, and components; Improve existing products and processes; and increase performance and market opportunities for companies through improved product life, longevity, durability, usability and/or enhanced functionality. For example, the creation of more sustainable materials through the use of conductive material or ability to function in extreme environments.
• Increase competitiveness of UK and SCR companies in priority sectors, including manufacturing, health care technologies and devices.
• Increase the number of small and medium sized enterprises engaged in knowledge exchange and collaboration.
• Improve the commercialisation and market entry of new or enhanced products or services including by small and medium sized enterprises.
• Increase investment in research and innovation, including by small and medium sized enterprises.
The instruments, detailed above, will be used primarily to support business engagement activities, contract research and external consultancy. However as appropriate a wide range of other activities including academic research and taught practical classes for undergraduate and post-graduate courses will be supported.
Lots 1&2 are primarily for use by the Biomolecular Sciences Research Centre (BMRC), within the Industry and Innovation Research Institute (I2RI). Lot 3 is primarily for use by the Materials and Engineering Research Institute (MERI) also within I2RI.
II.2.5) Award criteria
Quality criterion: Ability to meet essential technical requirements
/ Weighting: Pass/Fail
Quality criterion: The Instruments/Equipment Proposed
/ Weighting: 40%
Quality criterion: Samples
/ Weighting: 9%
Quality criterion: Usability, Operation and System Configuration
/ Weighting: 5%
Quality criterion: Build Quality
/ Weighting: 3%
Quality criterion: System Development and Functionality
/ Weighting: 3%
Quality criterion: Software Provision and Support
/ Weighting: 6%
Quality criterion: Cost and Impact of ownership
/ Weighting: 2%
Quality criterion: Delivery
/ Weighting: For Information Only
Quality criterion: Installation, Commissioning and Training
/ Weighting: 2%
Quality criterion: Warranty and Maintenance
/ Weighting: 7%
Quality criterion: Student Opportunities
/ Weighting: 3%
Quality criterion: Site Preparation
/ Weighting: For Information Only
Price
/ Weighting:
20
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
A High-Resolution Benchtop Micro Computerised Tomography (micro-CT) scanner
II.2.2) Additional CPV code(s)
33110000
II.2.3) Place of performance
NUTS code:
UKE32
II.2.4) Description of the procurement
The project is receiving up to £2.7M of funding from the England European Regional Development Fund as part of the European Structural and Investment Funds Growth Programme 2014-2020. The Ministry of Housing, Communities and Local Government (and in London the intermediate body Greater London Authority) is the Managing Authority for European Regional Development Fund. Established by the European Union, the European Regional Development Fund helps local areas stimulate their economic development by investing in projects which will support innovation, businesses, create jobs and local community regenerations. For more information visit https://www.gov.uk/european-growth-funding
The Northern Powerhouse is a key aspect of this Government's approach to addressing the productivity gap in the North and ensuring a stronger, more sustainable economy for all parts of the UK. Alongside over €1.5 billion of European Regional Development Fund support for businesses and communities across the North, the government has awarded £3.4 billion in three rounds of Growth Deals across the Northern Powerhouse.
The likely use of the MALDI Mass Spectrometer will be in the analysis of molecules in a range of biological and chemical samples. Industry sectors that this will impact will be: Chemical manufacturers, pharmaceutical companies, forensic testing, agricultural product manufacturers and food & beverage companies. The benefits / likely outcomes are efficacy and safety testing of existing or new products (validated research materials for marketing purposes, compliance with product regulations). Also, identification of mode of action of products (novel used of existing products).
The likely use of the Integrated AFM-Raman Imaging System will be in biotech, pharmaceuticals, high precision engineering, NHS, and Private healthcare centres and SMEs developing new products.
The likely use of the MicroCT (Computerised Tomography) Scanner will be in private healthcare centres and SMEs developing bone implants for downstream analysis. Companies undertaking R&D in biomaterials and bone material science applications in geology and environmental analysis. The benefits / likely outcomes aredevelopment of new materials for bone formation and regeneration. Non-destructive analysis of implants and testing of novel drugs.
The medium to longer term objectives, year 2 onwards, include work with business and academic partners to:
• Develop new materials, products, and components; Improve existing products and processes; and increase performance and market opportunities for companies through improved product life, longevity, durability, usability and/or enhanced functionality. For example, the creation of more sustainable materials through the use of conductive material or ability to function in extreme environments.
• Increase competitiveness of UK and SCR companies in priority sectors, including manufacturing, health care technologies and devices.
• Increase the number of small and medium sized enterprises engaged in knowledge exchange and collaboration.
• Improve the commercialisation and market entry of new or enhanced products or services including by small and medium sized enterprises.
• Increase investment in research and innovation, including by small and medium sized enterprises.
The instruments, detailed above, will be used primarily to support business engagement activities, contract research and external consultancy. However as appropriate a wide range of other activities including academic research and taught practical classes for undergraduate and post-graduate courses will be supported.
Lots 1&2 are primarily for use by the Biomolecular Sciences Research Centre (BMRC), within the Industry and Innovation Research Institute (I2RI). Lot 3 is primarily for use by the Materials and Engineering Research Institute (MERI) also within I2RI.
II.2.5) Award criteria
Quality criterion: Ability to meet essential technical requirements
/ Weighting: Pass/Fail
Quality criterion: The Instruments/Equipment Proposed
/ Weighting: 50%
Quality criterion: Usability, Operation and System Configuration
/ Weighting: 5%
Quality criterion: Build Quality
/ Weighting: 3%
Quality criterion: System Development and Functionality
/ Weighting: 3%
Quality criterion: Software Provision and Support
/ Weighting: 5%
Quality criterion: Cost and Impact of ownership
/ Weighting: 2%
Quality criterion: Delivery
/ Weighting: For Information Only
Quality criterion: Installation, Commissioning and Training
/ Weighting: 2%
Quality criterion: Warranty and Maintenance
/ Weighting: 7%
Quality criterion: Student Opportunities
/ Weighting: 3%
Quality criterion: Site Preparation
/ Weighting: For Information Only
Price
/ Weighting:
20
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 3
II.2.1) Title
An Atomic Force Microscopy (AFM) - Raman Spectrometer
II.2.2) Additional CPV code(s)
33114000
II.2.3) Place of performance
NUTS code:
UKE32
II.2.4) Description of the procurement
The project is receiving up to £2.7M of funding from the England European Regional Development Fund as part of the European Structural and Investment Funds Growth Programme 2014-2020. The Ministry of Housing, Communities and Local Government (and in London the intermediate body Greater London Authority) is the Managing Authority for European Regional Development Fund. Established by the European Union, the European Regional Development Fund helps local areas stimulate their economic development by investing in projects which will support innovation, businesses, create jobs and local community regenerations. For more information visit https://www.gov.uk/european-growth-funding
The Northern Powerhouse is a key aspect of this Government's approach to addressing the productivity gap in the North and ensuring a stronger, more sustainable economy for all parts of the UK. Alongside over €1.5 billion of European Regional Development Fund support for businesses and communities across the North, the government has awarded £3.4 billion in three rounds of Growth Deals across the Northern Powerhouse.
The likely use of the MALDI Mass Spectrometer will be in the analysis of molecules in a range of biological and chemical samples. Industry sectors that this will impact will be: Chemical manufacturers, pharmaceutical companies, forensic testing, agricultural product manufacturers and food & beverage companies. The benefits / likely outcomes are efficacy and safety testing of existing or new products (validated research materials for marketing purposes, compliance with product regulations). Also, identification of mode of action of products (novel used of existing products).
The likely use of the Integrated AFM-Raman Imaging System will be in biotech, pharmaceuticals, high precision engineering, NHS, and Private healthcare centres and SMEs developing new products.
The likely use of the MicroCT (Computerised Tomography) Scanner will be in private healthcare centres and SMEs developing bone implants for downstream analysis. Companies undertaking R&D in biomaterials and bone material science applications in geology and environmental analysis. The benefits / likely outcomes are development of new materials for bone formation and regeneration. Non-destructive analysis of implants and testing of novel drugs.
The medium to longer term objectives, year 2 onwards, include work with business and academic partners to:
• Develop new materials, products, and components; Improve existing products and processes; and increase performance and market opportunities for companies through improved product life, longevity, durability, usability and/or enhanced functionality. For example, the creation of more sustainable materials through the use of conductive material or ability to function in extreme environments.
• Increase competitiveness of UK and SCR companies in priority sectors, including manufacturing, health care technologies and devices.
• Increase the number of small and medium sized enterprises engaged in knowledge exchange and collaboration.
• Improve the commercialisation and market entry of new or enhanced products or services including by small and medium sized enterprises.
• Increase investment in research and innovation, including by small and medium sized enterprises.
The instruments, detailed above, will be used primarily to support business engagement activities, contract research and external consultancy. However as appropriate a wide range of other activities including academic research and taught practical classes for undergraduate and post-graduate courses will be supported.
Lots 1&2 are primarily for use by the Biomolecular Sciences Research Centre (BMRC), within the Industry and Innovation Research Institute
II.2.5) Award criteria
Quality criterion: Ability to meet essential technical requirements
/ Weighting: Pass/Fail
Quality criterion: The Instruments/Equipment Proposed
/ Weighting: 50%
Quality criterion: Usability, Operation and System Configuration
/ Weighting: 5%
Quality criterion: Build Quality
/ Weighting: 3%
Quality criterion: System Development and Functionality
/ Weighting: 3%
Quality criterion: Software Provision and Support
/ Weighting: 5%
Quality criterion: Cost and Impact of ownership
/ Weighting: 2%
Quality criterion: Delivery
/ Weighting: For Information Only
Quality criterion: Installation, Commissioning and Training
/ Weighting: 2%
Quality criterion: Warranty and Maintenance
/ Weighting: 7%
Quality criterion: Student Opportunities
/ Weighting: 3%
Quality criterion: Site Preparation
/ Weighting: For Information Only
Price
/ Weighting:
20
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Title: A mass spectrometry imaging system incorporating a matrix assisted laser desorption ionisation source, an electrospray source3 and nhplc/uplc system(s)
Title: A High-Resolution Benchtop Micro Computerised Tomography (micro-CT) scanner
The contract has been awarded to a group of economic operators:
No
The contract has been awarded to a group of economic operators:
No